Our analysis suggests that CHD4 mutations are found in different types of breast cancer, concurring alongside mutations in tumor suppressor genes or oncogenes including BRCA2, TP53, ERBB2, PIK3CA, E2F3, ATM, etc. (data not shown), as have been indicated by other authors’ (38). This evidence concerns the gene ERBB2 and breast carcinoma.